Complex encounters: nanoparticles in whole blood and their uptake into different types of white blood cells

Papers of special note have been highlighted as: ▪ of interest

References

• 1  Dobrovolskaia MA, Aggarwal P, Hall JB, Mcneil SE. Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution. Mol. Pharm.5(4),487–495 (2008).
  Medline CASGoogle Scholar
• 2  He Q, Zhang J, Shi J et al. The effect of PEGylation of mesoporous silica nanoparticles on nonspecific binding of serum proteins and cellular responses. Biomaterials31(6),1085–1092 (2010).
  Medline CASGoogle Scholar
• 3  Labarre D, Vauthier C, Chauvierre C, Petri B, Müller R, Chehimi MM. Interactions of blood proteins with poly(isobutylcyanoacrylate) nanoparticles decorated with a polysaccharidic brush. Biomaterials26(24),5075–5084 (2005).
  Medline CASGoogle Scholar
• 4  Beduneau A, Ma Z, Grotepas CB et al. Facilitated monocyte–macrophage uptake and tissue distribution of superparmagnetic iron-oxide nanoparticles. PLoS One4(2),e4343 (2009).
  MedlineGoogle Scholar
• 5  Lunov O, Syrovets T, Loos C et al. Differential uptake of functionalized polystyrene nanoparticles by human macrophages and a monocytic cell line. ACS Nano5(3),1657–1669 (2011).
  Medline CASGoogle Scholar
• 6  Mailänder V, Landfester K. Interaction of nanoparticles with cells. Biomacromolecules10(9),2379–2400 (2009).
  MedlineGoogle Scholar
• 7  Nowacek AS, Balkundi S, McMillan J et al. Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages. J. Control. Release150(2),204–211 (2011).
  Medline CASGoogle Scholar
• 8  Blank F, Gerber P, Rothen-Rutishauser B et al. Biomedical nanoparticles modulate specific CD4⁺ T cell stimulation by inhibition of antigen processing in dendritic cells. Nanotoxicology5(4),606–621 (2011).
  Medline CASGoogle Scholar
• 9  Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology20(45),455101 (2009).
  MedlineGoogle Scholar
• 10  Kim D, El-Shall H, Dennis D, Morey T. Interaction of PLGA nanoparticles with human blood constituents. Colloids Surf. B Biointerfaces40(2),83–91 (2005).
  MedlineGoogle Scholar
• 11  Sahli H, Tapon-Bretaudiere J, Fischer AM et al. Interactions of poly(lactic acid) and poly(lactic acid-co-ethylene oxide) nanoparticles with the plasma factors of the coagulation system. Biomaterials18(4),281–288 (1997).
  Medline CASGoogle Scholar
• 12  Adkins JN, Varnum SM, Auberry KJ et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol. Cell Proteomics1(12),947–955 (2002).
  Medline CASGoogle Scholar
• 13  Lesniak A, Campbell A, Monopoli MP, Lynch I, Salvati A, Dawson KA. Serum heat inactivation affects protein corona composition and nanoparticle uptake. Biomaterials31(36),9511–9518 (2010).
  Medline CASGoogle Scholar
• 14  Lundqvist M, Stigler J, Cedervall T et al. The evolution of the protein corona around nanoparticles: a test study. ACS Nano5(9),7503–7509 (2011).▪ Highlights the dynamic effects of the protein corona, and is, therefore, highly interesting.
  Medline CASGoogle Scholar
• 15  Neun BW, Dobrovolskaia MA. Method for in vitro analysis of nanoparticle thrombogenic properties. Methods Mol. Biol.697,225–235 (2011).▪ Elegant new study on the effect of nanoparticles on coagulation.
  Medline CASGoogle Scholar
• 16  Oslakovic C, Cedervall T, Linse S, Dahlback B. Polystyrene nanoparticles affecting blood coagulation. Nanomedicine8(6),981–986 (2011).
  MedlineGoogle Scholar
• 17  Rothen-Rutishauser BM, Schurch S, Haenni B, Kapp N, Gehr P. Interaction of fine particles and nanoparticles with red blood cells visualized with advanced microscopic techniques. Environ. Sci. Technol.40(14),4353–4359 (2006).
  Medline CASGoogle Scholar
• 18  Clift MJ, Gehr P, Rothen-Rutishauser B. Nanotoxicology: a perspective and discussion of whether or not in vitro testing is a valid alternative. Arch. Toxicol.85(7),723–731 (2011).
  Medline CASGoogle Scholar
• 19  Weiss CK, Lorenz MR, Landfester K, Mailänder V. Cellular uptake behavior of unfunctionalized and functionalized PBCA particles prepared in a miniemulsion. Macromol. Biosci.7(7),883–896 (2007).
  Medline CASGoogle Scholar
• 20  Weiss CK, Kohnle MV, Landfester K et al. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood–brain barrier permeation. ChemMedChem3(9),1395–1403 (2008).
  Medline CASGoogle Scholar
• 21  Lorenz MR, Kohnle MV, Dass M et al. Synthesis of fluorescent polyisoprene nanoparticles and their uptake into various cells. Macromol. Biosci.8(8),711–727 (2008).
  Medline CASGoogle Scholar
• 22  Paiphansiri U, Dausend J, Musyanovych A, Mailänder V, Landfester K. Fluorescent polyurethane nanocapsules prepared via inverse miniemulsion: surface functionalization for use as biocarriers. Macromol. Biosci.9(6),575–584 (2009).
  Medline CASGoogle Scholar
• 23  Mailänder V, Lorenz MR, Holzapfel V et al. Carboxylated superparamagnetic iron oxide particles label cells intracellularly without transfection agents. Mol. Imaging Biol.10(3),138–146 (2008).
  MedlineGoogle Scholar
• 24  Lorenz MR, Holzapfel V, Musyanovych A et al. Uptake of functionalized, fluorescent-labeled polymeric particles in different cell lines and stem cells. Biomaterials27(14),2820–2828 (2006).
  Medline CASGoogle Scholar
• 25  Zupke O, Distler E, Baumann D et al. Preservation of dendritic cell function upon labeling with amino functionalized polymeric nanoparticles. Biomaterials31(27),7086–7095 (2010).
  Medline CASGoogle Scholar
• 26  Musyanovych A, Rossmanith R, Tontsch C, Landfester K. Effect of hydrophilic co-monomer and surfactant type on the colloidal stability and size distribution of carboxyl- and amino-functionalized polystyrene particles prepared by miniemulsion polymerization. Langmuir23(10),5367–5376 (2007).
  Medline CASGoogle Scholar
• 27  Landfester K, Musyanovych A, Mailänder V. From polymeric particles to multifunctional nanocapsules for biomedical applications using the miniemulsion process. J. Polym. Sci. Pol. Chem.48(3),493–515 (2010).▪ Summarizes many papers from the authors’ group giving a good overview of how the miniemulsion process has evolved in a very versatile tool for synthesizing nanoparticles and nanocapsules.
  CASGoogle Scholar
• 28  Jiang X, Dausend J, Hafner M et al. Specific effects of surface amines on polystyrene nanoparticles in their interactions with mesenchymal stem cells. Biomacromolecules11(3),748–753 (2010).
  Medline CASGoogle Scholar
• 29  Jiang X, Musyanovych A, Rocker C, Landfester K, Mailänder V, Nienhaus GU. Specific effects of surface carboxyl groups on anionic polystyrene particles in their interactions with mesenchymal stem cells. Nanoscale3(5),2028–2035 (2011).
  Medline CASGoogle Scholar
• 30  Xia T, Kovochich M, Liong M, Zink JI, Nel AE. Cationic polystyrene nanosphere toxicity depends on cell-specific endocytic and mitochondrial injury pathways. ACS Nano2(1),85–96 (2008).
  Medline CASGoogle Scholar
• 31  Holzapfel V, Musyanovych A, Landfester K, Lorenz MR, Mailänder V. Preparation of fluorescent carboxyl and amino functionalized polystyrene particles by miniemulsion polymerization as markers for cells. Macromol. Chem. Phys.206(24),2440–2449 (2005).
  CASGoogle Scholar
• 32  Mayer A, Vadon M, Rinner B, Novak A, Wintersteiger R, Fröhlich E. The role of nanoparticle size in hemocompatibility. Toxicology258(2–3),139–147 (2009).
  Medline CASGoogle Scholar
• 33  Roy SC, Paulose M, Grimes CA. The effect of TiO2 nanotubes in the enhancement of blood clotting for the control of hemorrhage. Biomaterials28(31),4667–4672 (2007).
  Medline CASGoogle Scholar
• 34  Tavano R, Segat D, Reddi E et al. Procoagulant properties of bare and highly PEGylated vinyl-modified silica nanoparticles. Nanomedicine (Lond.)5(6),881–896 (2010).
  CASGoogle Scholar
• 35  Shapiro HM. Practical Flow Cytometry. John Wiley & Sons, NY, USA, 274–280 (2003).
  Google Scholar
• 36  Nunes P, Demaurex N. The role of calcium signaling in phagocytosis. J. Leukoc. Biol.88(1),57–68 (2010).
  Medline CASGoogle Scholar
• 37  Baba Y, Kurosaki T. Physiological function and molecular basis of STIM1-mediated calcium entry in immune cells. Immunol. Rev.231(1),174–188 (2009).
  Medline CASGoogle Scholar
• 38  Landfester K, Musyanovych A, Mailänder V. Polymeric nanoparticles as carrier systems: how does the material and surface charge affect cellular uptake? In: Clinical Chemistry Research. Mitchem BH, Sharnham CI (Eds). Nova Science Publishers Inc., NY, USA, 195–220 (2009).
  Google Scholar
• 39  Harush-Frenkel O, Rozentur E, Benita S, Altschuler Y. Surface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cells. Biomacromolecules9(2),435–443 (2008).▪ Elegant early study on how nanoparticle surface charge changes uptake and the further fate of nanoparticles.
  Medline CASGoogle Scholar
• 40  Bartneck M, Keul HA, Wambach M et al. Effects of nanoparticle surface-coupled peptides, functional endgroups, and charge on intracellular distribution and functionality of human primary reticuloendothelial cells. Nanomedicine doi:10.1016/j.nano.2012.02.012 (2012) (Epub ahead of print).
  MedlineGoogle Scholar
• 41  Zhao F, Zhao Y, Liu Y, Chang X, Chen C, Zhao Y. Cellular uptake, intracellular trafficking, and cytotoxicity of nanomaterials. Small7(10),1322–1337 (2011).
  Medline CASGoogle Scholar
• 101  International Organization for Standardization. Nanotechnologies – Terminology and definitions for nano-objects – Nanoparticle, nanofibre and nanoplate www.iso.org/iso/catalogue_detail?csnumber=44278
  Google Scholar
• 102  European Commission. Scientific Committee on Emerging and Newly Identified Health Risks. http://ec.europa.eu/health/scientific_committees/publications/index_en.htm
  Google Scholar